Neogen Corporation (NASDAQ: NEOG) Stock Competitors & Peer Comparison
See NEOG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NEOG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NEOG | $11.82 | -3.59% | 2.6B | 42.21 | $0.28 | N/A |
| ABT | $106.20 | +1.56% | 183.8B | 20.39 | $5.21 | +2.37% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $96.54 | -0.59% | 123.5B | 17.46 | $5.53 | +2.96% |
| SYK | $291.86 | -6.38% | 111.9B | 21.79 | $13.39 | +1.20% |
| BSX | $41.98 | -1.66% | 60.8B | 13.54 | $3.10 | N/A |
| EW | $92.01 | -2.57% | 53.1B | 34.09 | $2.70 | N/A |
| GEHC | $76.57 | +0.99% | 34.5B | 16.76 | $4.56 | +0.19% |
| DXCM | $82.29 | +2.95% | 31.1B | 32.28 | $2.55 | N/A |
| PHG | $26.92 | -0.74% | 26.2B | 15.39 | $1.75 | +3.68% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
NEOG vs ABT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ABT has a market cap of 183.8B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ABT trades at $106.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ABT's P/E ratio is 20.39. In terms of profitability, NEOG's ROE is -0.03%, compared to ABT's ROE of +0.09%. Regarding short-term risk, NEOG is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
NEOG vs BSX-PA Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, NEOG's ROE is -0.03%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, NEOG is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
NEOG vs MDT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MDT has a market cap of 123.5B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while MDT trades at $96.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas MDT's P/E ratio is 17.46. In terms of profitability, NEOG's ROE is -0.03%, compared to MDT's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
NEOG vs SYK Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SYK has a market cap of 111.9B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SYK trades at $291.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SYK's P/E ratio is 21.79. In terms of profitability, NEOG's ROE is -0.03%, compared to SYK's ROE of +0.16%. Regarding short-term risk, NEOG is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
NEOG vs BSX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BSX has a market cap of 60.8B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BSX trades at $41.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BSX's P/E ratio is 13.54. In terms of profitability, NEOG's ROE is -0.03%, compared to BSX's ROE of +0.14%. Regarding short-term risk, NEOG is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
NEOG vs EW Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, EW has a market cap of 53.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while EW trades at $92.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas EW's P/E ratio is 34.09. In terms of profitability, NEOG's ROE is -0.03%, compared to EW's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
NEOG vs GEHC Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, GEHC has a market cap of 34.5B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while GEHC trades at $76.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas GEHC's P/E ratio is 16.76. In terms of profitability, NEOG's ROE is -0.03%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, NEOG is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check GEHC's competition here
DexCom, Inc. (NASDAQ: DXCM)
NEOG vs DXCM Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, DXCM has a market cap of 31.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while DXCM trades at $82.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas DXCM's P/E ratio is 32.28. In terms of profitability, NEOG's ROE is -0.03%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, NEOG is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check DXCM's competition here
Koninklijke Philips N.V. (NYSE: PHG)
NEOG vs PHG Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PHG has a market cap of 26.2B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PHG trades at $26.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PHG's P/E ratio is 15.39. In terms of profitability, NEOG's ROE is -0.03%, compared to PHG's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
NEOG vs ZBH Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ZBH has a market cap of 18B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ZBH trades at $94.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ZBH's P/E ratio is 11.15. In terms of profitability, NEOG's ROE is -0.03%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, NEOG is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
NEOG vs ABMD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ABMD's P/E ratio is 65.36. In terms of profitability, NEOG's ROE is -0.03%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
NEOG vs GKOS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, GKOS has a market cap of 14.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while GKOS trades at $237.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas GKOS's P/E ratio is -281.83. In terms of profitability, NEOG's ROE is -0.03%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, NEOG is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check GKOS's competition here
Penumbra, Inc. (NYSE: PEN)
NEOG vs PEN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PEN trades at $318.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PEN's P/E ratio is 83.34. In terms of profitability, NEOG's ROE is -0.03%, compared to PEN's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
NEOG vs SWAV Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SWAV's P/E ratio is 78.76. In terms of profitability, NEOG's ROE is -0.03%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, NEOG is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
NEOG vs SNN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SNN has a market cap of 12.4B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SNN trades at $29.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SNN's P/E ratio is 20.05. In terms of profitability, NEOG's ROE is -0.03%, compared to SNN's ROE of +0.12%. Regarding short-term risk, NEOG is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SNN's competition here
Globus Medical, Inc. (NYSE: GMED)
NEOG vs GMED Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while GMED trades at $78.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas GMED's P/E ratio is 18.67. In terms of profitability, NEOG's ROE is -0.03%, compared to GMED's ROE of +0.12%. Regarding short-term risk, NEOG is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check GMED's competition here
Align Technology, Inc. (NASDAQ: ALGN)
NEOG vs ALGN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ALGN has a market cap of 10.7B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ALGN trades at $149.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ALGN's P/E ratio is 13.67. In terms of profitability, NEOG's ROE is -0.03%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, NEOG is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
NEOG vs BIO-B Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BIO-B trades at $386.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BIO-B's P/E ratio is -68.03. In terms of profitability, NEOG's ROE is -0.03%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, NEOG is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BIO-B's competition here
Insulet Corp. (NASDAQ: PODD)
NEOG vs PODD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PODD has a market cap of 10.4B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PODD trades at $149.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PODD's P/E ratio is 25.51. In terms of profitability, NEOG's ROE is -0.03%, compared to PODD's ROE of +0.27%. Regarding short-term risk, NEOG is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
NEOG vs BIO Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BIO has a market cap of 9.9B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BIO trades at $372.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BIO's P/E ratio is 40.08. In terms of profitability, NEOG's ROE is -0.03%, compared to BIO's ROE of +0.03%. Regarding short-term risk, NEOG is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
NEOG vs MASI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas MASI's P/E ratio is 44.43. In terms of profitability, NEOG's ROE is -0.03%, compared to MASI's ROE of +0.09%. Regarding short-term risk, NEOG is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKRP)
NEOG vs BRKRP Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BRKRP trades at $422.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BRKRP's P/E ratio is 229.49. In terms of profitability, NEOG's ROE is -0.03%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, NEOG is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BRKRP's competition here
Bruker Corporation (NASDAQ: BRKR)
NEOG vs BRKR Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BRKR has a market cap of 8.7B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BRKR trades at $57.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BRKR's P/E ratio is 28.69. In terms of profitability, NEOG's ROE is -0.03%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, NEOG is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BRKR's competition here
Haemonetics Corporation (NYSE: HAE)
NEOG vs HAE Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, HAE has a market cap of 5.4B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while HAE trades at $119.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas HAE's P/E ratio is 23.87. In terms of profitability, NEOG's ROE is -0.03%, compared to HAE's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
NEOG vs NARI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas NARI's P/E ratio is -59.24. In terms of profitability, NEOG's ROE is -0.03%, compared to NARI's ROE of -0.00%. Regarding short-term risk, NEOG is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
NEOG vs LIVN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while LIVN trades at $78.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas LIVN's P/E ratio is 18.76. In terms of profitability, NEOG's ROE is -0.03%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, NEOG is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
NEOG vs ITGR Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ITGR trades at $126.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ITGR's P/E ratio is 19.94. In terms of profitability, NEOG's ROE is -0.03%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, NEOG is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
NEOG vs IRTC Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while IRTC trades at $123.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas IRTC's P/E ratio is -287.02. In terms of profitability, NEOG's ROE is -0.03%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, NEOG is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check IRTC's competition here
AxoGen, Inc. (NASDAQ: AXGN)
NEOG vs AXGN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AXGN has a market cap of 2.9B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while AXGN trades at $49.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas AXGN's P/E ratio is 129.92. In terms of profitability, NEOG's ROE is -0.03%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, NEOG is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AXGN's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
NEOG vs TMDX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TMDX has a market cap of 2.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while TMDX trades at $65.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas TMDX's P/E ratio is 33.49. In terms of profitability, NEOG's ROE is -0.03%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, NEOG is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check TMDX's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
NEOG vs UFPT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while UFPT trades at $284.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas UFPT's P/E ratio is 29.03. In terms of profitability, NEOG's ROE is -0.03%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, NEOG is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
NEOG vs NUVA Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas NUVA's P/E ratio is 75.00. In terms of profitability, NEOG's ROE is -0.03%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, NEOG is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
NEOG vs INSP Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INSP has a market cap of 2B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while INSP trades at $68.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas INSP's P/E ratio is 29.97. In terms of profitability, NEOG's ROE is -0.03%, compared to INSP's ROE of +0.18%. Regarding short-term risk, NEOG is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
NEOG vs ESTA Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ESTA trades at $62.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ESTA's P/E ratio is -49.52. In terms of profitability, NEOG's ROE is -0.03%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, NEOG is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check ESTA's competition here
Butterfly Network, Inc. (NYSE: BFLY)
NEOG vs BFLY Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BFLY trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BFLY's P/E ratio is -26.62. In terms of profitability, NEOG's ROE is -0.03%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, NEOG is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BFLY's competition here
Novocure Ltd (NASDAQ: NVCR)
NEOG vs NVCR Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NVCR has a market cap of 1.5B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while NVCR trades at $13.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas NVCR's P/E ratio is -10.11. In terms of profitability, NEOG's ROE is -0.03%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, NEOG is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check NVCR's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
NEOG vs TNDM Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while TNDM trades at $19.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas TNDM's P/E ratio is -20.54. In terms of profitability, NEOG's ROE is -0.03%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, NEOG is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check TNDM's competition here
CONMED Corporation (NYSE: CNMD)
NEOG vs CNMD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CNMD has a market cap of 1.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CNMD trades at $44.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CNMD's P/E ratio is 9.74. In terms of profitability, NEOG's ROE is -0.03%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, NEOG is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
NEOG vs HSKA Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas HSKA's P/E ratio is -62.49. In terms of profitability, NEOG's ROE is -0.03%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, NEOG is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check HSKA's competition here
Avanos Medical, Inc. (NYSE: AVNS)
NEOG vs AVNS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas AVNS's P/E ratio is 27.77. In terms of profitability, NEOG's ROE is -0.03%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, NEOG is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AVNS's competition here
Enovis Corporation (NYSE: ENOV)
NEOG vs ENOV Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ENOV trades at $19.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ENOV's P/E ratio is 5.71. In terms of profitability, NEOG's ROE is -0.03%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, NEOG is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check ENOV's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
NEOG vs SILK Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SILK's P/E ratio is -18.96. In terms of profitability, NEOG's ROE is -0.03%, compared to SILK's ROE of -0.35%. Regarding short-term risk, NEOG is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
NEOG vs AORT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while AORT trades at $22.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas AORT's P/E ratio is 37.63. In terms of profitability, NEOG's ROE is -0.03%, compared to AORT's ROE of -0.01%. Regarding short-term risk, NEOG is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check AORT's competition here
Paragon 28, Inc. (NYSE: FNA)
NEOG vs FNA Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas FNA's P/E ratio is -19.83. In terms of profitability, NEOG's ROE is -0.03%, compared to FNA's ROE of -0.35%. Regarding short-term risk, NEOG is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check FNA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
NEOG vs LMRI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while LMRI trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas LMRI's P/E ratio is -22.20. In terms of profitability, NEOG's ROE is -0.03%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, NEOG is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
NEOG vs PRCT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PRCT trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PRCT's P/E ratio is -9.89. In terms of profitability, NEOG's ROE is -0.03%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, NEOG is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check PRCT's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
NEOG vs ATEC Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ATEC has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ATEC trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ATEC's P/E ratio is -117.42. In terms of profitability, NEOG's ROE is -0.03%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, NEOG is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check ATEC's competition here
CeriBell, Inc. (NASDAQ: CBLL)
NEOG vs CBLL Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CBLL trades at $26.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CBLL's P/E ratio is -15.11. In terms of profitability, NEOG's ROE is -0.03%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, NEOG is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CBLL's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
NEOG vs IART Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, IART has a market cap of 991.6M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while IART trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas IART's P/E ratio is 5.40. In terms of profitability, NEOG's ROE is -0.03%, compared to IART's ROE of +0.01%. Regarding short-term risk, NEOG is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check IART's competition here
IRadimed Corporation (NASDAQ: IRMD)
NEOG vs IRMD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, IRMD has a market cap of 980.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while IRMD trades at $76.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas IRMD's P/E ratio is 38.53. In terms of profitability, NEOG's ROE is -0.03%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, NEOG is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check IRMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
NEOG vs SIBN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SIBN has a market cap of 952.4M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SIBN trades at $21.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SIBN's P/E ratio is -62.50. In terms of profitability, NEOG's ROE is -0.03%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, NEOG is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check SIBN's competition here
Bioventus Inc. (NASDAQ: BVS)
NEOG vs BVS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BVS has a market cap of 910.2M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BVS trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BVS's P/E ratio is 17.53. In terms of profitability, NEOG's ROE is -0.03%, compared to BVS's ROE of +0.28%. Regarding short-term risk, NEOG is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BVS's competition here
Picard Medical, Inc. (AMEX: PMI)
NEOG vs PMI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PMI has a market cap of 857.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PMI trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PMI's P/E ratio is -6.96. In terms of profitability, NEOG's ROE is -0.03%, compared to PMI's ROE of -9.31%. Regarding short-term risk, NEOG is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
NEOG vs CSII Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CSII's P/E ratio is -20.83. In terms of profitability, NEOG's ROE is -0.03%, compared to CSII's ROE of -0.14%. Regarding short-term risk, NEOG is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CSII's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
NEOG vs PACB Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PACB has a market cap of 809.7M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PACB trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PACB's P/E ratio is -6.35. In terms of profitability, NEOG's ROE is -0.03%, compared to PACB's ROE of -49.62%. Regarding short-term risk, NEOG is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check PACB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
NEOG vs KIDS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, KIDS has a market cap of 806.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while KIDS trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas KIDS's P/E ratio is -26.19. In terms of profitability, NEOG's ROE is -0.03%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, NEOG is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check KIDS's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
NEOG vs CTKB Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CTKB has a market cap of 795.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CTKB trades at $6.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CTKB's P/E ratio is -32.42. In terms of profitability, NEOG's ROE is -0.03%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, NEOG is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CTKB's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
NEOG vs AHCO Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AHCO has a market cap of 792.2M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while AHCO trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas AHCO's P/E ratio is 11.86. In terms of profitability, NEOG's ROE is -0.03%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, NEOG is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AHCO's competition here
Varex Imaging Corporation (NASDAQ: VREX)
NEOG vs VREX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, VREX has a market cap of 782.2M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while VREX trades at $18.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas VREX's P/E ratio is 19.39. In terms of profitability, NEOG's ROE is -0.03%, compared to VREX's ROE of +0.05%. Regarding short-term risk, NEOG is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
NEOG vs INMD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INMD has a market cap of 760.7M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while INMD trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas INMD's P/E ratio is 9.18. In terms of profitability, NEOG's ROE is -0.03%, compared to INMD's ROE of +0.12%. Regarding short-term risk, NEOG is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check INMD's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
NEOG vs BBNX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BBNX has a market cap of 752.2M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BBNX trades at $16.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BBNX's P/E ratio is -10.13. In terms of profitability, NEOG's ROE is -0.03%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, NEOG is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BBNX's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
NEOG vs AVR Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AVR has a market cap of 615.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while AVR trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas AVR's P/E ratio is -3.26. In terms of profitability, NEOG's ROE is -0.03%, compared to AVR's ROE of -0.78%. Regarding short-term risk, NEOG is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
NEOG vs SRDX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SRDX's P/E ratio is -34.66. In terms of profitability, NEOG's ROE is -0.03%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, NEOG is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
NEOG vs APEN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas APEN's P/E ratio is -9.43. In terms of profitability, NEOG's ROE is -0.03%, compared to APEN's ROE of -0.85%. Regarding short-term risk, NEOG is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check APEN's competition here
ZimVie Inc. (NASDAQ: ZIMV)
NEOG vs ZIMV Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, NEOG's ROE is -0.03%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, NEOG is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
NEOG vs TCMD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TCMD has a market cap of 521.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while TCMD trades at $23.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas TCMD's P/E ratio is 21.33. In terms of profitability, NEOG's ROE is -0.03%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, NEOG is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
NEOG vs SGHT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SGHT has a market cap of 513.4M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SGHT trades at $9.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SGHT's P/E ratio is -16.64. In terms of profitability, NEOG's ROE is -0.03%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, NEOG is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SGHT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
NEOG vs SENS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SENS has a market cap of 503.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SENS trades at $9.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SENS's P/E ratio is -4.27. In terms of profitability, NEOG's ROE is -0.03%, compared to SENS's ROE of -1.66%. Regarding short-term risk, NEOG is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check SENS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
NEOG vs DCTH Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, DCTH has a market cap of 487M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while DCTH trades at $14.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas DCTH's P/E ratio is 1403.50. In terms of profitability, NEOG's ROE is -0.03%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, NEOG is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check DCTH's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
NEOG vs SSII Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SSII has a market cap of 471.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SSII trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SSII's P/E ratio is -39.17. In terms of profitability, NEOG's ROE is -0.03%, compared to SSII's ROE of -0.27%. Regarding short-term risk, NEOG is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check SSII's competition here
Cerus Corporation (NASDAQ: CERS)
NEOG vs CERS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CERS has a market cap of 460.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CERS trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CERS's P/E ratio is -75.91. In terms of profitability, NEOG's ROE is -0.03%, compared to CERS's ROE of -0.10%. Regarding short-term risk, NEOG is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
NEOG vs NPCE Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NPCE has a market cap of 420.8M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while NPCE trades at $12.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas NPCE's P/E ratio is -21.51. In terms of profitability, NEOG's ROE is -0.03%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, NEOG is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
NEOG vs RCEL Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, RCEL has a market cap of 389M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while RCEL trades at $15.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas RCEL's P/E ratio is -10.87. In terms of profitability, NEOG's ROE is -0.03%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, NEOG is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check RCEL's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
NEOG vs OFIX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, OFIX has a market cap of 366.8M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while OFIX trades at $9.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas OFIX's P/E ratio is -5.91. In terms of profitability, NEOG's ROE is -0.03%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, NEOG is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
NEOG vs CV Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CV has a market cap of 363.4M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CV trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CV's P/E ratio is -10.84. In terms of profitability, NEOG's ROE is -0.03%, compared to CV's ROE of -1.78%. Regarding short-term risk, NEOG is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CV's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
NEOG vs CLPT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CLPT has a market cap of 326.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CLPT trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CLPT's P/E ratio is -9.06. In terms of profitability, NEOG's ROE is -0.03%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, NEOG is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CLPT's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
NEOG vs SMLR Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas SMLR's P/E ratio is 3.92. In terms of profitability, NEOG's ROE is -0.03%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, NEOG is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SMLR's competition here
Quantum-Si incorporated (NASDAQ: QSI)
NEOG vs QSI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, QSI has a market cap of 289.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while QSI trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas QSI's P/E ratio is -3.16. In terms of profitability, NEOG's ROE is -0.03%, compared to QSI's ROE of -0.47%. Regarding short-term risk, NEOG is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
NEOG vs TMCI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TMCI has a market cap of 287.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while TMCI trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas TMCI's P/E ratio is -4.70. In terms of profitability, NEOG's ROE is -0.03%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, NEOG is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TMCI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
NEOG vs INFU Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INFU has a market cap of 278.8M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while INFU trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas INFU's P/E ratio is 34.15. In terms of profitability, NEOG's ROE is -0.03%, compared to INFU's ROE of +0.15%. Regarding short-term risk, NEOG is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
NEOG vs MGRM Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas MGRM's P/E ratio is -12.00. In terms of profitability, NEOG's ROE is -0.03%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, NEOG is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
NEOG vs PROF Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PROF has a market cap of 239.7M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while PROF trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas PROF's P/E ratio is -6.69. In terms of profitability, NEOG's ROE is -0.03%, compared to PROF's ROE of -0.56%. Regarding short-term risk, NEOG is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check PROF's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
NEOG vs TLSI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TLSI has a market cap of 226.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while TLSI trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas TLSI's P/E ratio is -2.19. In terms of profitability, NEOG's ROE is -0.03%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, NEOG is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TLSI's competition here
Nevro Corp. (NYSE: NVRO)
NEOG vs NVRO Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas NVRO's P/E ratio is -1.91. In terms of profitability, NEOG's ROE is -0.03%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, NEOG is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
NEOG vs ELMD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ELMD has a market cap of 223.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ELMD trades at $27.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ELMD's P/E ratio is 20.55. In terms of profitability, NEOG's ROE is -0.03%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, NEOG is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ELMD's competition here
RxSight, Inc. (NASDAQ: RXST)
NEOG vs RXST Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, RXST has a market cap of 201.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while RXST trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas RXST's P/E ratio is -4.30. In terms of profitability, NEOG's ROE is -0.03%, compared to RXST's ROE of -0.17%. Regarding short-term risk, NEOG is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
NEOG vs BSGM Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas BSGM's P/E ratio is -5.81. In terms of profitability, NEOG's ROE is -0.03%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, NEOG is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BSGM's competition here
Inogen, Inc. (NASDAQ: INGN)
NEOG vs INGN Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INGN has a market cap of 182.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while INGN trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas INGN's P/E ratio is -7.54. In terms of profitability, NEOG's ROE is -0.03%, compared to INGN's ROE of -0.13%. Regarding short-term risk, NEOG is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check INGN's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
NEOG vs MDGS Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas MDGS's P/E ratio is -0.27. In terms of profitability, NEOG's ROE is -0.03%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, NEOG is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
NEOG vs STIM Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, STIM has a market cap of 171.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while STIM trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas STIM's P/E ratio is -5.10. In terms of profitability, NEOG's ROE is -0.03%, compared to STIM's ROE of -1.51%. Regarding short-term risk, NEOG is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
NEOG vs QIPT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas QIPT's P/E ratio is -15.87. In terms of profitability, NEOG's ROE is -0.03%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, NEOG is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
NEOG vs FOCL Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, FOCL has a market cap of 158.5M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while FOCL trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas FOCL's P/E ratio is -4.09. In terms of profitability, NEOG's ROE is -0.03%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, NEOG is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check FOCL's competition here
Quanterix Corporation (NASDAQ: QTRX)
NEOG vs QTRX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, QTRX has a market cap of 137.4M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while QTRX trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas QTRX's P/E ratio is -1.14. In terms of profitability, NEOG's ROE is -0.03%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, NEOG is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check QTRX's competition here
Pulmonx Corporation (NASDAQ: LUNG)
NEOG vs LUNG Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, LUNG has a market cap of 129.1M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while LUNG trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas LUNG's P/E ratio is -2.59. In terms of profitability, NEOG's ROE is -0.03%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, NEOG is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check LUNG's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
NEOG vs CATX Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CATX has a market cap of 129M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while CATX trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas CATX's P/E ratio is -0.85. In terms of profitability, NEOG's ROE is -0.03%, compared to CATX's ROE of -0.42%. Regarding short-term risk, NEOG is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CATX's competition here
Owlet, Inc. (NYSE: OWLT)
NEOG vs OWLT Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, OWLT has a market cap of 118.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while OWLT trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas OWLT's P/E ratio is -29.07. In terms of profitability, NEOG's ROE is -0.03%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, NEOG is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check OWLT's competition here
iCAD, Inc. (NASDAQ: ICAD)
NEOG vs ICAD Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ICAD's P/E ratio is -20.37. In terms of profitability, NEOG's ROE is -0.03%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, NEOG is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
NEOG vs HJLI Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas HJLI's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.03%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, NEOG is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
NEOG vs ASXC Comparison November 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, NEOG is priced at $11.82 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 42.21, whereas ASXC's P/E ratio is -1.12. In terms of profitability, NEOG's ROE is -0.03%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, NEOG is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ASXC's competition here